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Abstract
Carbon nanotubes (CNTs) hold great promise to create new and better products, but their adverse 
health effect is a major concern. Human exposure to CNTs is primarily through inhalation and 
dermal contact, especially during the manufacturing and handling processes. Numerous animal 
studies have demonstrated the potential pulmonary and dermal hazards associated with CNT 
exposure, while in vitro studies have assessed the effects of CNT exposure on various cellular 
behaviors and have been used to perform mechanistic studies. In this review, we provide an 
overview of the pathological effects of CNTs and examine the acute and chronic effects of CNT 
exposure on lung and dermal cellular behaviors, beyond the generally discussed cytotoxicity. We 
then examine the linkage of cellular behaviors and disease pathogenesis, and discuss the pertinent 
mechanisms.
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Nanotechnology presents enormous opportunities to improve and even revolutionize the 
fields of electronics, energy, waste treatment, biosensors and medicine. Most benefits of 
nanotechnology result from the ability to engineer the essential structures of nanomaterial to 
achieve specific properties. Carbon nanotubes (CNTs) are a major class of nanomaterials 
possessing unique mechanical, electrical and thermal properties [1,2]. They are being 
produced on a massive scale with the estimated global market of approximately US$2 
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billion by 2014 [3,4]. CNTs are being used in diverse fields, including electronics, textiles, 
sporting goods, aerospace, drug delivery and bioimaging [5,6]. Such widespread use has led 
to the unprecedented avenues of human exposure. In terms of structure, CNTs are high 
aspect ratio nanomaterials comprised of single or concentrically stacked multiwalled 
graphene sheets rolled into a cylinder, referred to as single-walled (SW) or multiwalled 
(MW) CNTs, respectively. The potential health risks of CNT exposure have been raised, 
attributable to the following reasons: their small nanosized structure that makes them more 
reactive and toxic than larger particles; their high aspect ratio and mode of exposure similar 
to asbestos fibers, prompting a concern about their potential fiber-like toxicity; and their 
graphitic structure that is expected to have high durability and biopersistence [7,8]. 
Synthesis of CNTs by methods such as evaporation, vapor deposition and laser ablation 
often leaves residual metal catalysts such as cobalt, iron, nickel, molybdenum and 
contaminated amorphous carbon and fullerenes [9], which may contribute to the observed 
toxic effects of CNTs. In addition, the surface of CNTs can be modified and functionalized 
to introduce specific functions [10], increasing the diversity of available CNTs with different 
surface chemistry, purity, dimension, wall number and functionalization. All of these 
intrinsic physicochemical factors, as well as extrinsic factors, such as experimental 
conditions, can influence the observed biological activities of CNTs. Box 1 summarizes key 
factors influencing CNT bioactivities. More detailed information on the types and sources of 
CNTs, experimental conditions, and major findings are summarized and discussed in Table 
1. Specific discussions of CNT biological activities are provided in subsequent sections (also 
see [11–13]).
Due to their widespread use and possible human exposure, especially in occupational and 
environmental settings during manufacturing and disposal (Figure 1), it is important to 
determine the safety and potential hazards of CNTs. To date, most toxicity studies have 
focused on CNT exposure via inhalation and dermal contact, and evaluated their effect on 
general cytotoxicity [7–8,11]. In this review, we examine the various effects of CNT 
exposure on cellular behaviors as a result of pulmonary and dermal CNT exposure. We 
discuss the potential linkage of these cellular behaviors to the disease process and examine 
the underlying mechanisms.
Pulmonary exposure to CNTs
The major target organ of CNT exposure is the lung via inhalation. Inhalation exposure to 
CNTs has been evaluated in US research facilities with the report of average airborne CNT 
level of 10 μg/m3 [31] and high CNT level of 400 μg/m3 [32]. Although no reports on the 
adverse health effects of CNTs are available at present, due to the early developmental stage 
of CNTs and their usage, the National Institute for Occupational Safety and Health (NIOSH) 
has recently recommended the exposure limit (REL) of 1 μg/m3 of respirable element carbon 
as an 8-h time-weighted average (TWA). This recommendation is based on the current 
estimation from animal studies, which have been conducted using instillation, aspiration, 
and inhalation techniques to enable CNT exposure of rats and mice [33]. These studies have 
shown consistent adverse pulmonary effects, including lung inflammation, granuloma and 
fibrosis. The important findings of CNT pulmonary effects are described below.
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One of the first CNT toxicity studies was conducted by Lam et al. who investigated the 
effects of SWCNT with different metal impurities after intratracheal (it.) administration to 
the lungs of mice at the dosing concentrations of 0.1–0.5 mg [34]. The mice were 
toxicologically assessed at 7 and 90 days postexposure. All types of SWCNTs studied were 
found to induce persistent epithelioid granulomas in association with particle aggregates and 
lung inflammation in a dose- and time-dependent manner. Similar granuloma formation with 
SWCNT aggregates was observed in the it. study in rats [35]. Progressive interstitial fibrosis 
and alveolar wall thickening was reported in mice with SWCNT exposure via pharyngeal 
aspiration at 28 days postexposure onwards, the effect that was dependent on SWCNT 
dispersion status [36]. Lung inflammation and fibrosis were also observed in mice exposed 
by pharyngeal aspiration [37] and rats by it. administration to MWCNTs [38,39]. With 
regard to the effect of surface functionalization, Sager et al. recently reported that addition 
of the carboxylate (COOH) groups to MWCNT significantly reduced the inflammatory and 
fibrogenic responses after pharyngeal aspiration into mice [23], likely due to the decreased 
association with target lung cells.
To date, not many inhalation studies have been conducted. Short-term inhalation (nose-only) 
study of 5 mg/m3 SWCNT (5 h/day for 4 days) with mice revealed acute lung inflammation 
followed by the development of granulomas and persistent interstitial fibrosis [40]. For 
MWCNT exposure, lung fibrosis, but not mesothelioma, was observed in an inhalation 
(nose-only) study with mice exposed to 30 mg/m3 MWCNT for 6 h, but not to lower doses, 
for example 1 mg/m3 [41]. Mitchell et al. reported neither significant lung inflammation nor 
fibrosis upon 0.3–5 mg/m3 MWCNT inhalation (6 h/day for 14 days), although splenic 
immunosuppression was observed likely through an activation of cyclooxygenase at 1 
mg/m3 dose [42,43]. In mice with allergic asthma sensitized by ovalbumin, 100 mg/m3 
MWCNT inhalation for 6 h induced lung fibrosis at 14 days, whereas no fibrosis was 
observed in mice receiving ovalbumin or MWCNTs alone [44]. A more recent study by 
Sargent et al. using a multistage (initiation-promotion) carcinogenesis model in B6C3F1 
mice demonstrated that inhalation of 5 mg/m3 MWCNT (5 h/day, 5 days/week for 15 days) 
following an intraperitoneal (ip.) injection of DNA damaging agent methylcholanthrene 
(initiator) led to increased incidence and numbers of bronchioloalveolar adenomas and 
adenocarcinomas at 17 months postexposure as compared with MCA or MWCNT exposure 
alone (62 vs 22 or 14%) [45]. This finding indicates MWCNT as a tumor promoter but not 
tumor initiator in mice.
ip. injection studies exposing fiber particles to the mesothelial linings of the abdominal 
cavity in mice and rats were used as a surrogate for the mesothelial linings of pleural cavity 
surrounding the lungs for screening of the mesothelioma pathogenicity in humans [46]. It 
was first noted by Poland et al. that short-term ip. instillation of long MWCNT in wild-type 
mice caused asbestos-like granuloma, suggesting the potential linkage between CNT 
exposure and mesothelioma [47]. Further studies by Takagi et al. and Kanno et al. reported 
that a single ip. injection of MWCNT in heterozygous p53 mice caused mesothelioma 
[48,49]. However, it is worthy to note that the animal model used in these two studies was 
cancer sensitive, since heterozygous p53 mice have some background of spontaneous 
cancer. The mesothelioma pathogenicity of MWCNT was later observed by Nagai et al. in a 
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noncancer-prone rodent model of Fischer-344/Brown-Norway F1 hybrid rats [14]. In that 
study, the pathogenic effect of MWCNT was found to be associated with particle diameter. 
For example, thin and rigid MWCNTs (diameter: ~50 nm) were most pathogenic, whereas 
thick (diameter: ~150 nm) and tangled (diameter: ~2–20 nm) MWCNTs were less 
pathogenic. By contrast, Muller et al. and Liang et al. reported no mesothelioma formation 
after an ip. injection of MWCNT in rats and mice [50,51]. It is likely that the difference in 
animal species and/or exposure conditions used in these studies contributed to the observed 
discrepancies.
In vitro assessment of the CNT effects on lung cellular behaviors
Various in vitro studies using different lung cell types have been performed to evaluate the 
effects of CNTs on cellular behaviors. The models of these studies that describe the various 
cell types used and their origin as well as their role in disease pathogenesis are summarized 
in Table 2.
Acute effects of CNTs on lung cellular behaviors
Cell viability & apoptosis
Assessment of the cellular effects of CNTs has focused mainly on acute toxicity, which is 
commonly assessed by cell viability and apoptosis. Cell viability can be determined by 
various means such as cell membrane integrity using propidium iodide and trypan blue 
assays, and mitochondrial activity using formazan-based 3-(4,5-Dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT), 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide (XTT) and 4-(3-[4-Iodophenyl]-2-[4-nitrophenyl]-2H-5-
tetrazolio)-1,3-benzene disulfonate (WST-1) assays. Various CNTs under different 
treatment conditions have been studied. For example, Manna et al. demonstrated a dose-
dependent decrease in the viability (MTT assay) of human lung epithelial A549 and H1299 
cells after SWCNT treatment (0.1–10 μg/ml) [30]. Magrez et al. similarly observed the 
dose-dependent decrease in cell viability (MTT assay) of a set of lung epithelial cells 
including H596, H446 and Calu-1 cells after MWCNT exposure (0.002–0.2 μg/ml) for up to 
4 days [21]. The same study also reported a further reduction in cell viability upon treatment 
with MWCNT with surface-modified carbonyl, COOH, and hydroxyl groups. Subsequent 
studies by Davoren et al. and Wick et al. showed that aggregation of CNTs determines their 
cellular toxicity (MTT assay) in A549 lung epithelial cells and MSTO211H mesothelial 
cells [27,28]. By contrast, Pulskamp et al. reported no toxicity (WST-1 assay) in NR8383 rat 
alveolar macrophages and A459 lung epithelial cells after SWCNT or MWCNT exposure 
(5–100 μg/ml) for 24 h [25].
Apoptosis is a form of cell death that plays an essential role in the maintenance of tissue 
homeostasis. An excessive induction of apoptosis, however, could lead to organ dysfunction 
and failure, such as lung emphysema [54]. Assays of apoptosis are mainly based on the 
detection of unique morphological changes such as membrane blebbing, cell shrinkage, 
nuclear condensation and fragmentation. Several apoptotic studies using lung epithelial cells 
have been conducted. For examples, Ravichandran et al. demonstrated the induction of 
apoptosis in rat lung epithelial cells by MWCNT (0.5–10 μg/ml) after a 24-h exposure [61]. 
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Pacurari et al. demonstrated a dose- and time-dependent effect of raw SWCNT (5–600 
μg/cm2) containing nickel and yttrium catalysts on apoptosis of human lung epithelial 
BEAS-2B cells [62]. In the same study, SWCNT was found to induce MAPK, AP-1 and 
NF-κB, all of which recapitulate the key molecular signaling involved in lung 
carcinogenesis. A similar finding on MAPK, AP-1 and NF-κB activation by SWCNT (25–
50 μg/cm2) was observed in normal human and malignant mesothelial cells [56]. Notably, 
pristine graphene sheets (5–80 μg/ml) were also shown to trigger apoptosis of RAW 264.7 
macrophages partly through the MAPK pathway [19]. These findings suggest the possible 
linkage between CNT-induced molecular and cellular changes (e.g., apoptosis) and lung 
pathogenesis (e.g., cancer and mesothelioma).
Genotoxicity
Cancer is generally accepted as a disease of the genome as significant genomic alterations 
(e.g., point mutations, large deletions and amplifications) are observed in almost all forms of 
human cancer [63]. Genotoxicity refers to damage to genomic DNA that could potentially 
lead to mutations and eventually cancer. Several assays have been used to test the 
genotoxicity of CNTs in cultured lung cells, for example, comet, chromosomal, 
micronucleus and phosphorylated H2AX assays [64]. Exposure to SWCNT (25–50 μg/ml) 
caused a dose-dependent genotoxic effect in normal and malignant mesothelial cells as 
determined by comet assay and H2AX phosphorylation [56]. SWCNT and MWCNT were 
also found to be genotoxic in human bronchial BEAS-2B epithelial cells as evaluated by 
comet and micronucleus assays [65].
Paracellular permeability
Lung epithelium presents a protective barrier against inhaled particles through the formation 
of tight junction barrier, which limits the paracellular permeability of solutes and toxicants 
across the epithelium [66]. Alterations in the barrier function are therefore an important 
determinant of the interaction of xenobiotics with other compartments of the organisms. 
Tight junction barrier of the lung can be modeled by using Calu-3 lung epithelial cells 
grown on a permeable filter in culture, and analyzed by transepithelial electrical resistance 
(TEER) or mannitol flux measurements. Exposure to noncytotoxic MWCNT (100 μg/ml) for 
4 days caused a large drop in Calu-3 TEER and a parallel increase in mannitol permeability, 
while SWCNT (100 μg/ml) produced much smaller effects [67]. The presence of MWCNT 
and SWCNT in cell culture during the formation of tight junction significantly decreased the 
TEER. These findings suggest that MWCNT and SWCNT can interfere with the formation 
and/or maintenance of tight junction barrier of the lung.
Stimulation of inflammatory factors
Pulmonary exposure to CNTs leads to lung inflammation, the pathological condition that has 
been linked to the development of lung fibrosis and cancer. Animal studies demonstrated the 
involvement of various inflammatory cytokines and growth factors such as IL-1β, TGF-β 
and PDGF in CNT-induced lung fibrosis. For instance, Shvedova et al. demonstrated that 
SWCNT were potent inducer of TGF-β production in association with macrophage 
recruitment and lung fibrosis [36]. Ryman-Rassmussen et al. suggested that MWCNT 
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induced lung fibrosis through PDGF activation in accordance with TGF-β activation by 
ovalbumin [44]. PDGF, as a potent mitogen and chemoattractant, is known to stimulate 
proliferation and migration of lung fibroblasts, while TGF-β is known to stimulate collagen 
production and deposition [68]. Recently, the critical role of IL-1 signaling in CNT-induced 
inflammation has been demonstrated using transgenic mice. Knockout of IL-1 receptor 
(Il1r1) gene in C57Bl/6 mice (IL1R−/−) abrogated MWCNT-induced lung inflammation 
[69].
In vitro, the release of IL-1β, TGF-β and PDGF from THP-1 macrophages and BEAS-2B 
bronchial epithelial cells has been used to predict the lung fibrotic response to MWCNT 
[22,52]. Li et al. showed that, as compared with pristine MWCNT, anionic functionalized 
COOH and polyethylene glycol (PEG) MWCNT exhibited a weak stimulating effect on 
IL-1β, TGF-β and PDGF, while those with neutral and weak cationic functionalized amine 
(NH2) and sidewall NH2 showed intermediate effect, and the strong cationic functionalized 
polyetherimide MWCNT showed the most robust effect, the results that were in good 
agreement with the in vivo fibrogenic responses [22]. The production of TGF-β and PDGF 
from RAW264.7 macrophages by MWCNT was shown to promote the transformation of 
lung fibroblasts to myofibroblasts, a key step in the initiation and progression of pulmonary 
fibrosis [70]. Murphy et al. studied the effects of MWCNT of various lengths on the release 
of inflammatory cytokines IL-1β, TNF-α, IL-6 and chemokine IL-8 from Met5A pleural 
mesothelial cells and THP-1 macrophages [17]. The results showed that MWCNT (5 μg/
cm2) was able to induce cytokine release from macrophages in a length-dependent manner, 
which subsequently led to enhanced cytokine release from mesothelial cells, suggesting the 
mechanism for creating an inflammatory microenvironment in the pleural cavity by 
MWCNT.
Excessive cell growth & extracellular matrix production
Excessive production and deposition of extracellular matrix (ECM) is a hallmark of fibrosis 
[55]. Wang et al. demonstrated that SWCNT (0.08–0.24 μg/cm2) dose dependently induced 
proliferation of human lung fibroblasts and increased their production of ECM proteins 
including collagen I and III [29]. A similar fibroblast-stimulating effect was observed with 
MWCNT (0.02–0.06 μg/cm2) through the induction of FGF-2 [53]. In the same study, 
MWCNT was also shown to induce collagen production by lung fibroblasts in a dose-
dependent manner. These studies suggest that the induction of fibroblast proliferation and 
collagen production by CNTs might be key determining factors of CNT-induced lung 
fibrosis.
Angiogenesis
Angiogenesis or formation of new blood vessels has been implicated in the pathogenesis of 
lung fibrosis as indicated by the increased neovascularization and angiogenic mediators 
observed in the lungs of patients and animals with pulmonary fibrosis [58]. Azad et al. 
demonstrated that exposure of human lung fibroblasts to SWCNT (5–25 μg/ml) induced the 
secretion of angiogenic mediator TGF-β1 and VEGF in a dose-dependent manner [59]. 
These mediators from the lung fibroblasts stimulated angiogenesis of HUVEC endothelial 
cells. TGF-β1 and VEGF additionally have a direct effect on fibrogenesis by inducing 
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collagen production, suggesting that these two molecules may produce an additive effect 
through ECM and angiogenesis induction that contributes to CNT fibrosis.
Co-culture of human small airway epithelial cells (SAEC) and HMVEC endothelial cells 
represents the model for alveolar–capillary interaction of small airways in the lower 
respiratory tract. Synder-Talkington et al. found that exposure of HMVEC cells to 
MWCNT-stimulated SAEC cells in the Transwell® co-culture system increased the 
angiogenicity of HMVEC cells [60]. The authors suggest that this might be linked to the 
pathological angiogenesis in lung fibrosis.
Acute effects of CNTs & their linkage to lung fibrosis
As discussed above, various cellular events, including inflammation, angiogenesis, 
proliferation and ECM production, contribute to the development of lung fibrosis after CNT 
exposure. Figure 2 is a schematic representation summarizing the linkage between various 
cellular events and lung fibrogenesis.
Chronic effects of CNTs on lung cellular behaviors
Because of the similarity between CNTs and asbestos fibers in terms of high aspect ratio, 
route of exposure and biopersistence, there is a great concern about the potential 
carcinogenicity of CNTs. Inhaled CNTs have been shown to penetrate the alveolar 
epithelium, enter the interstitial compartment where the clearance rate is low [36,71–72] and 
subsequently migrate to the parietal pleural space [73]. As typical developmental period of 
fiber-induced lung cancer in humans is 30–40 years [74], no human data on CNT-induced 
cancer are yet available. To mimic the long-term carcinogenic process, our group has 
developed chronic exposure models in which human lung epithelial cells (e.g., BEAS-2B 
and SAEC cells) and pleural mesothelial cells (e.g., Met5A cells) were continuously 
exposed to low-dose (0.02 μg/cm2), physiologically relevant concentrations of SWCNT and 
MWCNT for a prolonged period of time (e.g., 4–6 months) [75–77]. These cells were 
chosen because they are cellular targets of human lung cancer and mesothelioma. The 
exposed cells were then assessed for various aggressive behaviors known to be cancer 
hallmarks, such as abnormal cell growth, acquired apoptosis resistance, increased motility 
and angiogenesis [78]. Figure 3 depicts CNT lung carcinogenesis model and summarizes the 
chronic effects of CNTs on lung cellular behaviors.
Cell growth & malignant transformation
Tissue homeostasis is the balance between cell death and proliferation. While disturbance in 
homeostasis that favors cell apoptosis could contribute to organ failure or dysfunction as 
mentioned above, excessive cell growth could lead to progressive diseases, such as cancer 
[79]. Chronic exposure to low-dose SWCNT and MWCNT (0.02 μg/cm2) was reported to 
induce cell growth of human lung epithelial and mesothelial cells [75–77]. The exposed 
cells were also shown to grow under anchorage-independent conditions (e.g., on soft agar), 
an indicator of malignant transformation [75,76]. A similar finding was observed in chronic 
MWCNT-exposed lung epithelial cells at a higher concentration (0.16 μg/cm2) [80]. Using 
whole genome microarray analysis and ingenuity pathway analysis, Wang et al. reported the 
Luanpitpong et al. Page 7













activation of cancer-related canonical pathways in chronic SWCNT- and MWCNT-exposed 
lung epithelial cells similar to that observed in asbestos-exposed cells [76]. Western blot 
analysis further showed the overexpression of proto-oncoproteins (e.g., PPARγ, cFOS and c-
Myc) and downregulation of tumor suppressor proteins (e.g., inhibin-α and p53) in the 
SWCNT- and MWCNT-exposed cells, supporting the cellular cancer-like behaviors.
Acquired apoptosis resistance
Apoptosis plays an essential role in the removal of mutated or transformed cells, and its 
disruption contributes to abnormal cell growth and malignancy [81]. Acquired apoptosis 
resistance promotes cell survival during the carcinogenic process against endogenous 
antigrowth signals and immune cell killing mechanisms [82]. Chronic exposure of lung 
epithelial cells to SWCNT (0.02 μg/cm2) resulted in acquired apoptosis resistance to the 
CNT itself and to other apoptosis inducers including death ligands such as TNF-α and 
chemotherapeutic agents such as etoposide [75]. Aberrant p53 signaling was shown to be 
involved in CNT apoptosis resistance, consistent with the findings that most human cancers 
have mutated or inactivated p53 [83].
Cell migration & invasion
Cell migration is a general movement of cells from one location to another, while cell 
invasion is defined as the migration of cells through the 3D tissue structures, for example, 
ECM or basement membrane [84]. Cell migration and invasion are key determinants of 
tumor progression and metastasis [85,86]. To enter blood and lymphatic vessels for 
dissemination into the systemic circulation, tumor cells must migrate or invade through 
certain barriers, for example, epithelial and vascular basement membrane and stromal ECM 
[87]. Chronic exposure of human lung epithelial or mesothelial cells to SWCNT and 
MWCNT (0.02 μg/cm2) induced migration and invasion of the cells similar to asbestos-
exposed cells [75–77]. MMP-2 was identified as the key ECM enzyme responsible for the 
increased migration and invasion of CNT-transformed mesothelial cells based on microarray 
data and gene knockdown studies [77].
Angiogenesis
The oxygen and nutrients supplied through blood vessels are crucial for cell functions and 
survival [88]. With the unlimited proliferative capability of tumor cells, an adequate supply 
of the nutrients and oxygen is necessary, or else the tumor cells may become apoptotic or 
necrotic. Tumor angiogenesis must develop in order to keep the tumor cells growing and 
spreading, and therefore it is an important factor in tumor progression and metastasis [86]. 
Tumor cells release angiogenic mediators such as VEGF, TGF-β, TNF-α and PDGF to 
trigger endothelial cell proliferation and capillary formation. Conditioned medium from 
chronic SWCNT- and MWCNT-exposed lung cells caused a significant increase in 
endothelial tube formation as indicated by the increased number of branch nodes and more 
complex pattern of capillary tubes, indicating the increased angiogenicity of chronic CNT-
exposed cells [75,76].
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The tumorigenicity of chronic SWCNT and MWCNT-exposed cells was assessed in a 
xenograft mouse model [75,80]. When the cells were subcutaneously injected into the hind 
flanks of immunodeficient mice, tumors were observed, whereas a similar injection of 
control cells gave no tumors [75,80]. Histological analysis of CNT-derived tumors showed 
classical cancer cell morphology, including the presence of multinucleated cells, an indicator 
of mitotic dysfunction [89]. Using a high-resolution comparative genomic hybridization 
technique, Wu et al. demonstrated chromosomal aberrations in chronic MWCNT-exposed 
lung cells particularly in the chromosome 2q31–32 [80]. HOXD9/D13 was further identified 
as the region contributing to MWCNT carcinogenesis.
Dermal exposure to CNTs
CNT exposure through skin/dermal contact can occur during the manufacturing and 
handling [8,11]. Dermal exposure to carbon materials has previously been reported to cause 
carbon fiber dermatitis [90]. However, in vivo assessment of the CNT dermal effects is 
limited. Koyama et al. demonstrated that implantation of SWCNT and MWCNT into the 
subcutaneous tissues of mice induced granuloma with entrapped CNT agglomerates after 3 
weeks of exposure [91], consistent with the earlier finding by Sato et al. showing 
granuloma-like structures in the rat skin after MWCNT implantation [92]. Murray et al. 
investigated the topical effects of SWCNT in mice and showed an increase in skin bi-fold 
thickness, an indicator of edema and inflammation, after topical exposure to SWCNT (40–
160 μg/mouse) for 5 days [93]. These studies suggest that there is a dermal hazard 
associated with CNT exposure and that the dermal response is primarily inflammatory in 
nature.
In vitro assessment of the CNT effects on dermal cellular behaviors
Assessment of the dermal effects of CNTs has focused on human keratinocytes and dermal 
fibroblasts. Keratinocytes are the predominant cell type in the skin epidermis, the outer 
epithelial layer of the skin, while dermal fibroblasts are cells that live within the dermis to 
generate and maintain skin connective tissue [94]. To date, only the acute effects of CNTs 
on dermal cellular behaviors have been reported, which are summarized and discussed 
below.
Acute effects of CNTs on dermal cellular behaviors
Cell viability
An early study by Shvedova et al. demonstrated that exposure of human HaCaT 
keratinocytes to SWCNT (0.06–0.24 mg/ml) for 18 h caused a dose-dependent decrease in 
cell viability as determined by the Alamar blue assay [26]. Transmission electron 
micrographs revealed ultrastructural alterations to both mitochondria and nuclei after 
SWCNT (0.24 mg/ml) exposure. Likewise, exposure of HaCaT cells to MWCNT (0.025–1 
mg/ml) for 24 h decreased cell viability; however, no cytotoxicity (MTT assay) of MWCNT 
(1 mg/ml) was observed in the human skin equivalent model called 3D EpiDerm™ 
Luanpitpong et al. Page 9













[(Epi-200; Mat-Tek Co., MA, USA)[95]. In addition, MWCNT (0.001–0.1 mg/ml) was 
found to be toxic (MTT assay) on human dermal fibroblasts after a 24-h exposure [96].
Genotoxicity
The genotoxicity of MWCNT was evaluated by Patlolla et al. in normal human dermal 
fibroblasts using comet and DNA ladder assays [96]. Exposure of MWCNT (40–400 μg/ml) 
for 48 h caused comet tail formation at all concentrations tested and DNA ladder formation 
at the highest dose. The genotoxicity of SWCNT (0.5–30 μg/ml) was reported by Cveticanin 
et al. in normal human dermal fibroblasts after 24-hour exposure using phosphorylated 
H2AX assay [97]. It was suggested that CNTs are efficient in interacting with DNA due to 
their similarity in dimension [96].
Inflammation
Studies by Witzmann and Monteiro-Riviere, and Zhang et al. demonstrated that SWCNT 
and MWCNT induced proinflammatory cytokines, such as IL-8 in HEK keratinocytes 
[98,99]. Using human skin equivalent model EpiDerm-FT™, Murray et al. showed an 
increase in IL-12, IL-6 and IFN-γ release in parallel with increased collagen production and 
dermis thickness after SWCNT (75 μg) exposure for 18 h [93]. These findings strengthen the 
involvement of inflammation in the dermal effects of CNTs.
Cell adhesion
Cell adhesion maintains contact between neighboring cells and substrata, and is important in 
proper cell signaling for cellular functions such as cell growth, migration, differentiation and 
tissue organization. Zhang et al. investigated the effects of MWCNT (20–50 μg/ml) on cell 
adhesion of primary human dermal fibroblasts and NIH 3T3 murine embryonic fibroblasts 
[100]. They showed that MWCNT exposure for 24 h decreased cell adhesion in both cell 
types, possibly through a decrease in adhesion-related genes including fibronectin, laminin 
and focal adhesion kinase.
Cell migration & wound healing
Cell migration contributes to tissue repair and regeneration during wound healing. In the 
initial state of tissue repair, fibroblasts from surrounding tissues proliferate and migrate into 
the wound area. Fibroblasts then generate ECM, while keratinocytes at the wound edge 
multiply and migrate towards the wound bed [101]. Treatment of human dermal fibroblasts 
and NIH 3T3 fibroblasts with MWCNT (25–50 μg/ml) for 24 h reduced the migratory 
activity of the cells by 20–40%, as determined by Transwell and scratch wound healing 
assays [100]. In the same study, MWCNT was shown to disrupt the assembly of F-actin 
stress fibers, which may contribute to the decreased cell migration.
Conclusions & future perspective
With the rapid development and widespread use of CNTs, increasing human exposure to the 
nanomaterial is expected. Therefore, it is important to determine their health hazards in a 
timely manner because of their potential pathogenicity. A detailed understanding of the 
biological activities and pathogenesis mechanisms is required to aid their toxicological 
Luanpitpong et al. Page 10













assessment. Numerous animal studies have demonstrated the overall pulmonary and dermal 
hazards associated with CNT exposure. In vitro studies have been used to assess the specific 
effects of CNT exposure on cellular behaviors and elucidate the underlying mechanisms. In 
this review, we examine the acute and chronic effects of CNT exposure on lung and dermal 
cellular behaviors beyond the generally discussed cytotoxicity, and evaluate their linkage to 
disease pathogenesis. For instance, acute exposure to CNTs was shown to induce 
inflammatory cytokine release by macrophages and lung epithelial cells, ECM production 
by lung fibroblasts, and angiogenesis by endothelial cells, all of which are key 
characteristics of lung fibrosis (Figure 2). Chronic exposure to CNTs induces neoplastic 
transformation of human lung epithelial and mesothelial cells with aggressive cancer-like 
behaviors (Figure 3).
With regards to the carcinogenicity of CNTs, it should be noted that although some animal 
and cell culture studies pointed out that chronic exposure to CNTs could induce or promote 
lung cancer and/or mesothelioma, negative findings were also reported. Therefore, more 
rigorous and systemic studies, especially with human exposure, are needed to ascertain the 
carcinogenicity of CNTs. As the typical developmental period of fiber-induced lung cancer 
in humans is 30–40 years, more rapid experimental models or alternate assays that are 
predictive of human carcinogenic responses are greatly needed. For the time being, prudent 
adoption of prevention strategies and implementation of exposure control are strongly 
advised.
Conflicting results regarding the pathologic effects and underlying mechanisms of CNTs 
could possibly be due to the use of different types of tested CNTs with various variables, 
experimental models and conditions (Table 1). There is a pressing need to develop a library 
of CNTs with well-defined physicochemical properties and standardized methodologies to 
elucidate the structure–activity relationships. Because of the great variety of CNTs with 
different purity and physicochemical properties, such as length, diameter, functionalization 
and surface chemistry, high-throughput screening assays that are predictive of the in vivo 
pathological responses are needed. The use of mechanism-based biomarkers might serve as 
a platform for high-throughput screening of CNT pathogenicity. In addition, it is of 
significant importance to establish appropriate dosimetry standards for nanotoxicological 
research since most studies to date have used unrealistically high concentrations of 
nanomaterials that may not be relevant to real-life exposure conditions.
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Box 1. Notable variable factors affecting carbon nanotube biological 
activities
Intrinsic physicochemical properties
• Particle size (diameter) and length
• Particle shape
• Wall number
• Particle surface chemistry
• Surface area
• Surface functionalization
• Presence of metal impurities
Extrinsic factors
• Tested cell types or animals
• Experimental conditions
• Dispersion status (agglomeration)
• Dose (concentration)
• Exposure time
• Test assays and sensitivity
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Pulmonary exposure to carbon nanotubes
• Carbon nanotubes (CNTs) can come into contact with the human body mainly 
through inhalation and dermal exposure. Inhalation exposure can lead to 
biopersistence and are therefore more potentially pathogenic.
• Animal models of CNT pulmonary exposure revealed adverse health effects, 
including lung inflammation, granuloma and fibrosis. CNTs have also been 
shown to induce mesothelioma after an intraperitoneal injection, raising a 
concern about their potential lung mesotheliogenicity.
In vitro assessment of the CNT effects on lung cellular behaviors
• Various lung cell types, including epithelial, mesothelial, endothelial, fibroblast 
and immune cells, have been used to investigate the effects of CNTs on lung 
cell behaviors.
• Acute CNT exposure can induce cytotoxicity, genotoxicity and permeability 
alterations depending on their physicochemical properties and exposure 
conditions. CNTs have been shown to induce cytokine release, extracellular 
matrix production and angiogenesis in vitro that have been linked to fibrosis in 
vivo.
• Chronic, low-dose CNT exposure causes neoplastic transformation of human 
lung epithelial and mesothelial cells exhibiting aggressive cancer-like behaviors.
Dermal exposure to CNTs
• To date, studies of CNT dermal exposure are limited.
• However, existing data have pointed out that the dermal responses to CNT 
exposure are primarily inflammatory in nature.
In vitro assessment of the CNT effects on dermal cellular behaviors
• The major cell types used to investigate the dermal effects of CNTs are 
keratinocytes and dermal fibroblasts.
• Acute CNT exposure decreases cell viability and initiates the inflammatory 
response of keratinocytes. CNTs have been shown to induce genotoxicity and 
alter cellular behaviors such as cell adhesion, migration, and wound healing of 
dermal fibroblasts. No studies on the effects of chronic CNT exposure on the 
dermal system have been reported to date.
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Sources of human carbon nanotubeexposure and physicochemical factors influencingcarbon 
nanotube bioactivities.
CNT: Carbon nanotube.
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Various cellular behaviors involved in carbon nanotube-induced lung fibrosis.
CNT: Carbon nanotube; ECM: Extracellular matrix.
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Lung models for carcinogenesis studies and chronic effects of carbon nanotube exposure on 
aggressive cellular behaviors.
CNT: Carbon nanotube.
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Table 2
Lung cell models for in vitro assessment of carbon nanotube pathogenicity.
Cell lines Origin Roles in pathogenesis
Lung epithelial cells
A549 Human alveolar type II epithelial 
cells (adenocarcinoma)
Lung epithelial cells are the primary targets of CNT lung exposure and 
carcinogenesis. They are also involved in lung fibrosis by regulating 
fibroblast activities, for example, proliferation, migration and ECM 
production, through the release of profibrogenic mediators [22,52–53]. In 
contrast, apoptosis of lung epithelial cells can lead to emphysema and the 
breakdown of lung tissue [54]
H1299, H596, H446, Calu-1 Human lung epithelial cells 
(carcinoma)
HNBE, BEAS-2B Human normal and SV40-
immortalized bronchial epithelial 
cells
SAEC Human small airway epithelial 
cells
Calu-3 Human sub-bronchial gland 
epithelial cells (adenocarcinoma)
Lung fibroblasts
CRL-1490 (WI-38), NHLF Human normal lung fibroblasts Lung fibroblasts represent one of the major cell types in lung interstitium. 
Their excessive proliferation and overproduction of ECM underlie lung 
fibrosis [29,55]V79 Chinese hamster lung fibroblasts
Pleural mesothelial cells
NM, Met5A Human normal and SV40-
immortalized mesothelial cells
Cellular studies using mesothelial cells are reported to mimic important 
biological events involved in mesothelioma development [56]
MM, MSTO211H Human malignant mesothelial 
cells (mesothelioma)
Immune cells
THP-1 Human monocytes, which can 
differentiate into macrophage-like 
cells
Immune cells, particularly macrophages, are the front line of body 
immune defense in response to foreign bodies, e.g. engulfing them by 
phagocytosis [57]
RAW264.7 Mouse leukemic monocyte 
macrophages
NR8383 Rat alveolar macrophages
Endothelial cells
HUVEC, HMVEC Human umbilical vein or 
microvascular endothelial cells
Angiogenesis, an increasing number of new capillaries, has been linked to 
lung fibrosis [58,59]. In addition, the co-culture of small airway epithelial 
cells and HMVEC cells was employed to model the alveolar–capillary 
interaction in the lower respiratory tract [60]
CNT: Carbon nanotube; ECM: Extracellular matrix; HMVEC: Human dermal microvascular endothelial cells.
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